Group One Trading’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,847
Closed -$40.5K 8356
2025
Q4
$45.2K Buy
+3,847
New +$41.5K ﹤0.01% 5682
2024
Q3
Sell
-9,541
Closed -$149K 7102
2024
Q2
$132K Sell
9,541
-4,700
-33% -$66.6K ﹤0.01% 3732
2024
Q1
$224K Buy
+14,241
New +$220K ﹤0.01% 3474
2023
Q4
Sell
-17,840
Closed -$292K 7895
2023
Q3
$219K Buy
+17,840
New +$265K ﹤0.01% 3719
2023
Q1
Sell
-6,248
Closed -$89K 7683
2022
Q4
$57.7K Sell
6,248
-44,518
-88% -$415K ﹤0.01% 4878
2022
Q3
$437K Buy
+50,766
New +$504K ﹤0.01% 3362
2019
Q1
Sell
-18,406
Closed -$320K 5171
2018
Q4
$232K Buy
18,406
+14,558
+378% +$217K ﹤0.01% 2567
2018
Q3
$59K Buy
+3,848
New +$53.2K ﹤0.01% 3874
2015
Q3
Sell
-22
Closed -$136 5067
2015
Q2
$0 Buy
+22
New +$113 ﹤0.01% 5044
2014
Q2
Sell
-7,421
Closed -$24.7K 5393
2014
Q1
$26K Sell
7,421
-100
-1% -$375 ﹤0.01% 4087
2013
Q4
$27K Buy
+7,521
New +$26.1K ﹤0.01% 4075

Other funds holding NEO

Group One Trading's NEO Position: Q1 2026 in Review

Group One Trading sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 3,847 shares — an estimated $40.5K sold.

Group One Trading first reported a position in NEO in Q4 2013 and held it in 11 quarters. The position peaked at $437K in Q3 2022. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Group One Trading reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 3,847 NeoGenomics shares in Q1 2026, an estimated $40.5K.
  • Group One Trading first reported a position in NeoGenomics in Q4 2013 and held it in 11 quarters.
  • Group One Trading's NeoGenomics position peaked at $437K in Q3 2022.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.